Evaluation of (124)I PET/CT and (124)I PET/MRI in the management of patients with differentiated thyroid cancer

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1006-10. doi: 10.1007/s00259-016-3334-4.

Authors

Laurent Dercle¹, Désirée Deandreis¹, Marie Terroir¹, Sophie Leboulleux¹, Jean Lumbroso¹, Martin Schlumberger²

Affiliations

¹ Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy and University Paris Saclay, 114 rue Edouard Vaillant, 94800, Villejuif Cédex, France.
² Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy and University Paris Saclay, 114 rue Edouard Vaillant, 94800, Villejuif Cédex, France. martin.schlumberger@gustaveroussy.fr.

PMID: 26928579
DOI: 10.1007/s00259-016-3334-4

No abstract available

Publication types

Editorial
Evaluation Study

MeSH terms

Humans
Iodine Radioisotopes*
Magnetic Resonance Imaging*
Positron Emission Tomography Computed Tomography*
Radiometry
Thyroid Neoplasms / diagnostic imaging*

Substances

Iodine Radioisotopes